{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:13:03Z","timestamp":1791231183632,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00234-026-03945-6","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T06:51:04Z","timestamp":1771311064000},"page":"1915-1925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spectral presaturation with inversion recovery provides superior neuromelanin imaging for Parkinson\u2019s disease evaluation compared to magnetization transfer"],"prefix":"10.1007","volume":"68","author":[{"given":"Tomoki","family":"Imokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Kagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"3945_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for parkinson\u2019s disease: MDS-PD clinical diagnostic criteria. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"3945_CR2","doi-asserted-by":"crossref","unstructured":"Kouli A, Torsney KM, Kuan W-L (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon 3\u201326","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"3945_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/brain\/awad300","volume":"147","author":"P Trujillo","year":"2024","unstructured":"Trujillo P, Aumann MA, Claassen DO (2024) Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function. Brain 147:337\u2013351. https:\/\/doi.org\/10.1093\/brain\/awad300","journal-title":"Brain"},{"key":"3945_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jmri.28414","volume":"57","author":"N He","year":"2023","unstructured":"He N, Chen Y, LeWitt PA et al (2023) Application of neuromelanin MR imaging in Parkinson disease. J Magn Reson Imaging 57:337\u2013352. https:\/\/doi.org\/10.1002\/jmri.28414","journal-title":"J Magn Reson Imaging"},{"key":"3945_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00234-013-1199-9","volume":"55","author":"S Kitao","year":"2013","unstructured":"Kitao S, Matsusue E, Fujii S et al (2013) Correlation between pathology and neuromelanin MR imaging in parkinson\u2019s disease and dementia with lewy bodies. Neuroradiology 55:947\u2013953. https:\/\/doi.org\/10.1007\/s00234-013-1199-9","journal-title":"Neuroradiology"},{"key":"3945_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","volume":"113","author":"NI Keren","year":"2015","unstructured":"Keren NI, Taheri S, Vazey EM et al (2015) Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. NeuroImage 113:235\u2013245. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.03.020","journal-title":"NeuroImage"},{"key":"3945_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","volume":"31","author":"SJ Cho","year":"2021","unstructured":"Cho SJ, Bae YJ, Kim J-M et al (2021) Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis. Eur Radiol 31:1268\u20131280. https:\/\/doi.org\/10.1007\/s00330-020-07240-7","journal-title":"Eur Radiol"},{"key":"3945_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1148\/radiol.2016160662","volume":"283","author":"ST Schwarz","year":"2017","unstructured":"Schwarz ST, Xing Y, Tomar P et al (2017) In vivo assessment of brainstem depigmentation in Parkinson disease: potential as a severity marker for multicenter studies. Radiology 283:789\u2013798. https:\/\/doi.org\/10.1148\/radiol.2016160662","journal-title":"Radiology"},{"key":"3945_CR9","doi-asserted-by":"publisher","first-page":"e26544","DOI":"10.1002\/hbm.26544","volume":"45","author":"N Shaff","year":"2023","unstructured":"Shaff N, Erhardt E, Nitschke S et al (2023) Comparison of automated and manual quantification methods for neuromelanin-sensitive MRI in parkinson\u2019s disease. Hum Brain Mapp 45:e26544. https:\/\/doi.org\/10.1002\/hbm.26544","journal-title":"Hum Brain Mapp"},{"key":"3945_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","volume":"17","author":"M Sasaki","year":"2006","unstructured":"Sasaki M, Shibata E, Tohyama K et al (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia Nigra in parkinson\u2019s disease. NeuroReport 17:1215\u20131218. https:\/\/doi.org\/10.1097\/01.wnr.0000227984.84927.a7","journal-title":"NeuroReport"},{"key":"3945_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/mds.26201","volume":"30","author":"G Castellanos","year":"2015","unstructured":"Castellanos G, Fern\u00e1ndez-Seara MA, Lorenzo-Betancor O et al (2015) Automated neuromelanin imaging as a diagnostic biomarker for parkinson\u2019s disease: automated neuromelanin image for PD. Mov Disord 30:945\u2013952. https:\/\/doi.org\/10.1002\/mds.26201","journal-title":"Mov Disord"},{"key":"3945_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JPD-171135","volume":"7","author":"M Fabbri","year":"2017","unstructured":"Fabbri M, Reim\u00e3o S, Carvalho M et al (2017) Substantia Nigra neuromelanin as an imaging biomarker of disease progression in parkinson\u2019s disease. J Parkinsons Dis 7:491\u2013501. https:\/\/doi.org\/10.3233\/JPD-171135","journal-title":"J Parkinsons Dis"},{"key":"3945_CR13","doi-asserted-by":"publisher","first-page":"e0151191","DOI":"10.1371\/journal.pone.0151191","volume":"11","author":"H Kawaguchi","year":"2016","unstructured":"Kawaguchi H, Shimada H, Kodaka F et al (2016) Principal component analysis of multimodal neuromelanin MRI and dopamine transporter PET data provides a specific metric for the nigral dopaminergic neuronal density. PLoS ONE 11:e0151191. https:\/\/doi.org\/10.1371\/journal.pone.0151191","journal-title":"PLoS ONE"},{"key":"3945_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00234-013-1171-8","volume":"55","author":"K Ogisu","year":"2013","unstructured":"Ogisu K, Kudo K, Sasaki M et al (2013) 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia Nigra Pars compacta for diagnosis of parkinson\u2019s disease. Neuroradiology 55:719\u2013724. https:\/\/doi.org\/10.1007\/s00234-013-1171-8","journal-title":"Neuroradiology"},{"key":"3945_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2463\/mrms.tn.2019-0167","volume":"20","author":"M Kusama","year":"2021","unstructured":"Kusama M, Sato N, Kimura Y, Miyagi K (2021) Quick MR neuromelanin imaging using a chemical shift selective pulse. Magn Reson Med Sci 20:106\u2013111. https:\/\/doi.org\/10.2463\/mrms.tn.2019-0167","journal-title":"Magn Reson Med Sci"},{"key":"3945_CR16","doi-asserted-by":"publisher","unstructured":"Kusama M, Kimura Y, Yoneyama M et al (2024) Comparison of 3D magnetization-transfer- and spectral-presaturation-with-inversion-recovery-based neuromelanin imaging. Magn Reson Med Sci advpub:mp.2023-0095. https:\/\/doi.org\/10.2463\/mrms.mp.2023-0095","DOI":"10.2463\/mrms.mp.2023-0095"},{"key":"3945_CR17","doi-asserted-by":"publisher","first-page":"e0209842","DOI":"10.1371\/journal.pone.0209842","volume":"14","author":"K-D Tona","year":"2019","unstructured":"Tona K-D, van Osch MJP, Nieuwenhuis S, Keuken MC (2019) Quantifying the contrast of the human locus coeruleus in vivo at 7 Tesla MRI. PLoS ONE 14:e0209842. https:\/\/doi.org\/10.1371\/journal.pone.0209842","journal-title":"PLoS ONE"},{"key":"3945_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/brainsci9120335","volume":"9","author":"G Zupan","year":"2019","unstructured":"Zupan G, \u0160uput D, Pirto\u0161ek Z, Vovk A (2019) Semi-automatic signature-based segmentation method for quantification of neuromelanin in substantia Nigra. Brain Sci 9:335. https:\/\/doi.org\/10.3390\/brainsci9120335","journal-title":"Brain Sci"},{"key":"3945_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/mds.23722","volume":"26","author":"ST Schwarz","year":"2011","unstructured":"Schwarz ST, Rittman T, Gontu V et al (2011) T1-Weighted MRI shows stage\u2010dependent substantia Nigra signal loss in parkinson\u2019s disease. Mov Disord 26:1633\u20131638. https:\/\/doi.org\/10.1002\/mds.23722","journal-title":"Mov Disord"},{"key":"3945_CR20","doi-asserted-by":"publisher","first-page":"e70123","DOI":"10.1002\/nbm.70123","volume":"38","author":"BG Andikoetxea","year":"2025","unstructured":"Andikoetxea BG, Mart\u00edn-Bastida A, Vidorreta M et al (2025) Neuromelanin contrast optimization and improved visualization of the substantia Nigra in a 3D gradient-echo sequence with magnetization transfer. NMR Biomed 38:e70123. https:\/\/doi.org\/10.1002\/nbm.70123","journal-title":"NMR Biomed"},{"key":"3945_CR21","doi-asserted-by":"publisher","first-page":"117810","DOI":"10.1016\/j.neuroimage.2021.117810","volume":"230","author":"N He","year":"2021","unstructured":"He N, Ghassaban K, Huang P et al (2021) Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage parkinson\u2019s disease. NeuroImage 230:117810. https:\/\/doi.org\/10.1016\/j.neuroimage.2021.117810","journal-title":"NeuroImage"},{"key":"3945_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54294\/uvnhin","volume":"2","author":"B Avants","year":"2009","unstructured":"Avants B, Tustison N, Song G (2009) Advanced normalization tools: V1.0. Insight J 2:1\u201335. https:\/\/doi.org\/10.54294\/uvnhin","journal-title":"Insight J"},{"key":"3945_CR23","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/s1053-8119(09)70884-5","volume":"47","author":"VS Fonov","year":"2009","unstructured":"Fonov VS, Evans AC, McKinstry RC et al (2009) Unbiased nonlinear average age-appropriate brain templates from birth to adulthood. NeuroImage 47:S102. https:\/\/doi.org\/10.1016\/s1053-8119(09)70884-5","journal-title":"NeuroImage"},{"key":"3945_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sdata.2018.63","volume":"5","author":"WM Pauli","year":"2018","unstructured":"Pauli WM, Nili AN, Tyszka JM (2018) A high-resolution probabilistic in vivo atlas of human subcortical brain nuclei. Sci Data 5:1\u201313. https:\/\/doi.org\/10.1038\/sdata.2018.63","journal-title":"Sci Data"},{"key":"3945_CR25","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1007\/s00429-017-1464-5","volume":"222","author":"K-D Tona","year":"2017","unstructured":"Tona K-D, Keuken MC, de Rover M et al (2017) In vivo visualization of the locus coeruleus in humans: quantifying the test-retest reliability. Brain Struct Funct 222:4203\u20134217. https:\/\/doi.org\/10.1007\/s00429-017-1464-5","journal-title":"Brain Struct Funct"},{"key":"3945_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12883-023-03350-z","volume":"23","author":"Q Liu","year":"2023","unstructured":"Liu Q, Wang P, Liu C et al (2023) An investigation of neuromelanin distribution in substantia Nigra and locus coeruleus in patients with parkinson\u2019s disease using neuromelanin-sensitive MRI. BMC Neurol 23:301. https:\/\/doi.org\/10.1186\/s12883-023-03350-z","journal-title":"BMC Neurol"},{"key":"3945_CR27","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1007\/s11604-023-01452-9","volume":"41","author":"S Oshima","year":"2023","unstructured":"Oshima S, Fushimi Y, Miyake KK et al (2023) Denoising approach with deep learning-based reconstruction for neuromelanin-sensitive MRI: image quality and diagnostic performance. Jpn J Radiol 41:1216\u20131225. https:\/\/doi.org\/10.1007\/s11604-023-01452-9","journal-title":"Jpn J Radiol"},{"key":"3945_CR28","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00259-018-3976-5","volume":"45","author":"H Matsuda","year":"2018","unstructured":"Matsuda H, Murata M, Mukai Y et al (2018) Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging 45:1405\u20131416. https:\/\/doi.org\/10.1007\/s00259-018-3976-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3945_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/nbm.683","volume":"14","author":"RM Henkelman","year":"2001","unstructured":"Henkelman RM, Stanisz GJ, Graham SJ (2001) Magnetization transfer in MRI: a review. NMR Biomed 14:57\u201364. https:\/\/doi.org\/10.1002\/nbm.683","journal-title":"NMR Biomed"},{"key":"3945_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/mrm.22034","volume":"62","author":"W Shin","year":"2009","unstructured":"Shin W, Gu H, Yang Y (2009) Incidental magnetization transfer contrast by fat saturation Preparation pulses in multislice Look-Locker echo planar imaging. Magn Reson Med 62:520\u2013526. https:\/\/doi.org\/10.1002\/mrm.22034","journal-title":"Magn Reson Med"},{"key":"3945_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/mds.28934","volume":"37","author":"Y Xing","year":"2022","unstructured":"Xing Y, Sapuan AH, Mart\u00edn-Bastida A et al (2022) Neuromelanin-MRI to quantify and track nigral depigmentation in parkinson\u2019s disease: A multicenter longitudinal study using template-based standardized analysis. Mov Disord 37:1028\u20131039. https:\/\/doi.org\/10.1002\/mds.28934","journal-title":"Mov Disord"},{"key":"3945_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13550-015-0087-1","volume":"5","author":"SR Suwijn","year":"2015","unstructured":"Suwijn SR, van Boheemen CJ, de Haan RJ et al (2015) The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with parkinson\u2019s disease or clinically uncertain parkinsonism: a systematic review. EJNMMI Res 5:12. https:\/\/doi.org\/10.1186\/s13550-015-0087-1","journal-title":"EJNMMI Res"},{"key":"3945_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fnagi.2016.00196","volume":"8","author":"IU Isaias","year":"2016","unstructured":"Isaias IU, Trujillo P, Summers P et al (2016) Neuromelanin imaging and dopaminergic loss in parkinson\u2019s disease. Front Aging Neurosci 8:196. https:\/\/doi.org\/10.3389\/fnagi.2016.00196","journal-title":"Front Aging Neurosci"},{"key":"3945_CR34","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/ene.14009","volume":"26","author":"A Okuzumi","year":"2019","unstructured":"Okuzumi A, Hatano T, Kamagata K et al (2019) Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced parkinson\u2019s disease? Eur J Neurol 26:1408\u20131416. https:\/\/doi.org\/10.1111\/ene.14009","journal-title":"Eur J Neurol"},{"key":"3945_CR35","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/mds.28531","volume":"36","author":"R Gaurav","year":"2021","unstructured":"Gaurav R, Yahia-Cherif L, Pyatigorskaya N et al (2021) Longitudinal changes in neuromelanin MRI signal in parkinson\u2019s disease: A progression marker. Mov Disord 36:1592\u20131602. https:\/\/doi.org\/10.1002\/mds.28531","journal-title":"Mov Disord"},{"key":"3945_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00702-017-1688-9","volume":"124","author":"T Hatano","year":"2017","unstructured":"Hatano T, Okuzumi A, Kamagata K et al (2017) Neuromelanin MRI is useful for monitoring motor complications in parkinson\u2019s and PARK2 disease. J Neural Transm (Vienna) 124:407\u2013415. https:\/\/doi.org\/10.1007\/s00702-017-1688-9","journal-title":"J Neural Transm (Vienna)"},{"key":"3945_CR37","doi-asserted-by":"publisher","first-page":"116457","DOI":"10.1016\/j.neuroimage.2019.116457","volume":"208","author":"K Wengler","year":"2019","unstructured":"Wengler K, He X, Abi-Dargham A, Horga G (2019) Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and Voxelwise analyses. NeuroImage 208:116457. https:\/\/doi.org\/10.1016\/j.neuroimage.2019.116457","journal-title":"NeuroImage"},{"key":"3945_CR38","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/mds.28615","volume":"36","author":"B Huynh","year":"2021","unstructured":"Huynh B, Fu Y, Kirik D et al (2021) Comparison of locus coeruleus pathology with nigral and forebrain pathology in parkinson\u2019s disease. Mov Disord 36:2085\u20132093. https:\/\/doi.org\/10.1002\/mds.28615","journal-title":"Mov Disord"},{"key":"3945_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00276-012-0979-y","volume":"34","author":"P Fernandes","year":"2012","unstructured":"Fernandes P, Regala J, Correia F, Gon\u00e7alves-Ferreira AJ (2012) The human locus coeruleus 3-D stereotactic anatomy. Surg Radiol Anat 34:879\u2013885. https:\/\/doi.org\/10.1007\/s00276-012-0979-y","journal-title":"Surg Radiol Anat"},{"key":"3945_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-020-00914-9","volume":"8","author":"H Geut","year":"2020","unstructured":"Geut H, Hepp DH, Foncke E et al (2020) Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series. Acta Neuropathol Commun 8:39. https:\/\/doi.org\/10.1186\/s40478-020-00914-9","journal-title":"Acta Neuropathol Commun"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-03945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-026-03945-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-03945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:17:04Z","timestamp":1785518224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-026-03945-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3945"],"URL":"https:\/\/doi.org\/10.1007\/s00234-026-03945-6","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the National Center of Neurology and Psychiatry.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}